Fifty-two clinical isolates of Nocardia asteroides were tested by agar dilution for their susceptibility to 25 antimicrobial agents. In general, susceptibility could not be predicted based on the antibiotic class tested. However, the beta-lactams, including third-generation cephalosporins, were generally ineffective (MIC for 90% of the organisms [MIC90], between 64 and >256 ,ug/ml), whereas minocycline and doxycycline were generally effective (MIC90, 4 and 8 ,ug/ml, respectively). Cycloserine was not effective below 60 pug/ml. The MIC50 and MIC90 of sulfamethoxazole was 16 and 32 jxg/ml, respectively, and that of trimethoprim varied widely (16 and >256 ,ug/ml, respectively). Based on MIC90 data, only doxycycline, minocycline, sulfamethoxazole, and imipenem could be applied empirically.
Nocardia infections are often treated with sulfonamides or trimethoprim-sulfamethoxazole (14, 15) . Reports of treatment failures with these regimens, especially in disseminated or central nervous system infections (15) , emphasize the need for alternative therapies. In the past, various therapeutic agents have been suggested, but variation in susceptibility testing procedures and as-yet-undefined factors have led to conflicting results (1, 5, 12, 17) . Recent in vitro studies performed with a standardized testing procedure have indicated that ampicillin (5), amikacin (7) , cefamandole (17) , minocycline (1) , and imipenem (6, 11) may be effective in the treatment of nocardiosis. However, conflicting data on ampicillin (5, 17) and general incompatability of aminoglycosides with long-term therapy demonstrated the need for further investigation. The purpose of this study was to test the susceptibility of Nocardia asteroides to antimicrobial agents which may more closely fit the clinical requirements for therapy of nocardial disease.
MATERIALS AND METHODS
Organisms. Fifty-two human isolates of N. asteroides were obtained from the University of California at Davis, the Santa Clara Valley Institute of Medical Research, Stanford University, the National Animal Disease Center (Ames, Iowa), and the University of Utah. Isolates were obtained from a variety of Nocardia infections, including pulmonary nocardiosis, soft tissue infection, disseminated disease in organ transplant patients, and central nervous system disease.
Isolates were identified by colonial morphology, staining characteristics, and the ability of each organism to hydrolyze xanthine, casein, or tyrosine according to the Manual of Clinical Microbiology (10 Susceptibility testing. Isolates to be tested were stored in glycerol at -20°C or in sterile milk at -70°C and then passed onto Saboraud dextrose agar before testing. The inoculum was prepared by inoculating brain heart infusion (BHI) broth from the Saboraud medium and incubating it at 35°C for 4 to 5 days. To increase the homogeneity of the organism suspensions, sterile glass beads (1.0 mm in diameter) were added to the culture tubes and cultures were mixed with a vortex mixer twice daily during incubation.
Agar dilution susceptibility was performed with twofold dilutions of the antibiotics according to the recommendations of the International Collaborative Study on susceptibility testing (9) . The turbidity of the inoculum was adjusted to equal a 0.5 McFarland standard, and the media were inoculated with a Steers replicator. This procedure produced an average inoculum size of 3 x 104 CFU. Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923 were also included as controls. The inoculated plates were incubated at 35°C for 48 h and then examined for growth to determine the MIC. The MIC was defined as the lowest concentration of antimicrobial agent resulting in complete inhibition (sulfonamides, 80% inhibition) of visible growth.
RESULTS
A comparison of strain growth in different broth media was made. Although all the isolates grew in BHI and tryptic soy broths, growth was sustained longer and more nearly homogeneous suspensions were obtained in BHI broth. Two of the isolates did not grow in MH broth, and among those that did grow, cellular aggregation was marked.
For N. asteroides, the range of MICs, the MIC for 50% of An inoculum effect has been shown to influence the susceptibility patterns of N. asteroides (14) . Beaman and Bourgeois (2) (11) recently demonstrated therapeutic success in six cases of nocardiosis treated with a cefuroxime-amikacin combination. There appeared to be no uniform in vitro susceptibility to other cephalosporins. Tsukamura (16) indicated the possibility of the antineoplastic agent 5-fluorouracil providing some prophylaxis against N. asteroides in patients undergoing chemotherapy with 5-fluorouracil; however, our data indicate that N. asteroides is not susceptible to 5-fluorouracil.
Unfortunately, there are numerous reports of the use of cycloserine in N. asteroides infections. However, because of toxicity, cycloserine serum levels should be kept at <30 ,g/ml (13) , and according to our data this would preclude any inhibition of N. asteroides. Also, D-cycloserine has been used to obtain cell wall-deficient forms of Nocardia in vitro (2) (3) (4) , and since L forms may be an important part of pathogenesis due to Nocardia (4, 8) , drugs which may induce them should be approached with some caution.
The broad range of MICs shown in Table 1 suggest that nocardial antibiotic susceptibility is related to the isolate. Such data and the difficulty encountered in developing uniform growth of Nocardia emphasize the need for careful evaluation of in vitro susceptibility data. Routine susceptibility testing of all N. asteroides isolates is recommended when a primary compound with emperic efficacy cannot be used.
